| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | ZBTB38 ZEB1 VEZF1 ZNF658 DPF3 ZFP91 ZNF799 ZEB2 ZNF443 ZFX ZNF44 | 3.11e-06 | 679 | 54 | 11 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZBTB38 ZEB1 VEZF1 ZNF658 DPF3 ZFP91 ZNF799 ZEB2 ZNF443 ZFX ZNF44 | 3.84e-06 | 694 | 54 | 11 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZBTB38 ZEB1 VEZF1 ZNF658 DPF3 ZFP91 ZNF799 ZEB2 ZNF443 ZFX ZNF44 | 1.09e-05 | 775 | 54 | 11 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZBTB38 ZEB1 VEZF1 ZNF658 DPF3 ZFP91 ZNF799 ZEB2 ZNF443 ZFX ZNF44 | 1.12e-05 | 777 | 54 | 11 | PS00028 |
| Domain | Znf_C2H2-like | ZBTB38 ZEB1 VEZF1 ZNF658 DPF3 ZFP91 ZNF799 ZEB2 ZNF443 ZFX ZNF44 | 1.40e-05 | 796 | 54 | 11 | IPR015880 |
| Domain | Znf_C2H2 | ZBTB38 ZEB1 VEZF1 ZNF658 DPF3 ZFP91 ZNF799 ZEB2 ZNF443 ZFX ZNF44 | 1.56e-05 | 805 | 54 | 11 | IPR007087 |
| Domain | ZnF_C2H2 | ZBTB38 ZEB1 VEZF1 ZNF658 DPF3 ZFP91 ZNF799 ZEB2 ZNF443 ZFX ZNF44 | 1.62e-05 | 808 | 54 | 11 | SM00355 |
| Domain | Di19_Zn_binding_dom | 1.71e-04 | 7 | 54 | 2 | IPR008598 | |
| Domain | zf-Di19 | 1.71e-04 | 7 | 54 | 2 | PF05605 | |
| Domain | WWE | 5.32e-04 | 12 | 54 | 2 | PS50918 | |
| Domain | WWE | 5.32e-04 | 12 | 54 | 2 | PF02825 | |
| Domain | WWE-dom | 5.32e-04 | 12 | 54 | 2 | IPR004170 | |
| Domain | zf-C2H2 | 7.93e-04 | 693 | 54 | 8 | PF00096 | |
| Domain | DEP | 1.83e-03 | 22 | 54 | 2 | PF00610 | |
| Domain | DEP | 1.83e-03 | 22 | 54 | 2 | PS50186 | |
| Domain | DEP | 1.83e-03 | 22 | 54 | 2 | SM00049 | |
| Domain | DEP_dom | 2.00e-03 | 23 | 54 | 2 | IPR000591 | |
| Pubmed | ZEB1 SUGP2 VEZF1 DPF3 PEG10 ZFP91 NIP7 PSMB6 RERE FAR1 MGA ZEB2 | 1.88e-06 | 1429 | 55 | 12 | 35140242 | |
| Pubmed | The Zeb proteins δEF1 and Sip1 may have distinct functions in lens cells following cataract surgery. | 2.46e-06 | 2 | 55 | 2 | 25082886 | |
| Pubmed | ZEBs: Novel Players in Immune Cell Development and Function. | 2.46e-06 | 2 | 55 | 2 | 30956067 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 28416756 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20025777 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20424117 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 12609600 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 24306957 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 20375168 | ||
| Pubmed | Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma. | 2.46e-06 | 2 | 55 | 2 | 29476046 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 22213144 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 21747944 | ||
| Pubmed | Functional conservation of zinc-finger homeodomain gene zfh1/SIP1 in Drosophila heart development. | 2.46e-06 | 2 | 55 | 2 | 16957952 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 37948583 | ||
| Pubmed | The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2. | 2.46e-06 | 2 | 55 | 2 | 37819755 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 28133913 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 34550965 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 22892238 | ||
| Pubmed | 4.25e-06 | 418 | 55 | 7 | 34709266 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 23412770 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 21890822 | ||
| Pubmed | TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression. | 7.36e-06 | 3 | 55 | 2 | 31933004 | |
| Pubmed | Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2. | 7.36e-06 | 3 | 55 | 2 | 24968735 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 29052277 | ||
| Pubmed | Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran. | 7.36e-06 | 3 | 55 | 2 | 31244281 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 34226299 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 17615296 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 26556542 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 26823172 | ||
| Pubmed | A miRNA signature associated with human metastatic medullary thyroid carcinoma. | 7.36e-06 | 3 | 55 | 2 | 24127332 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 18376396 | ||
| Pubmed | p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. | 7.36e-06 | 3 | 55 | 2 | 21518799 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 18411277 | ||
| Pubmed | miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM. | 7.36e-06 | 3 | 55 | 2 | 25833697 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 26022123 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 21411626 | ||
| Pubmed | BMP4 signaling mediates Zeb family in developing mouse tooth. | 7.36e-06 | 3 | 55 | 2 | 22350174 | |
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 24165969 | ||
| Pubmed | 7.36e-06 | 3 | 55 | 2 | 29302045 | ||
| Pubmed | Rap1 GTPase is required for mouse lens epithelial maintenance and morphogenesis. | 9.48e-06 | 26 | 55 | 3 | 26212757 | |
| Pubmed | Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression. | 1.47e-05 | 4 | 55 | 2 | 25301070 | |
| Pubmed | miR-200b regulates cell migration via Zeb family during mouse palate development. | 1.47e-05 | 4 | 55 | 2 | 22261924 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 17360662 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 23381389 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 28247944 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 16598713 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 31679088 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 29200203 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 21079000 | ||
| Pubmed | The MicroRNA 29 Family Promotes Type II Cell Differentiation in Developing Lung. | 1.47e-05 | 4 | 55 | 2 | 27215389 | |
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 18829540 | ||
| Pubmed | ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8+ T cell fates. | 2.45e-05 | 5 | 55 | 2 | 29449309 | |
| Pubmed | 2.45e-05 | 5 | 55 | 2 | 12743039 | ||
| Pubmed | Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. | 2.45e-05 | 5 | 55 | 2 | 12743038 | |
| Pubmed | A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. | 2.45e-05 | 5 | 55 | 2 | 19651985 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.81e-05 | 774 | 55 | 8 | 15302935 | |
| Pubmed | 3.67e-05 | 6 | 55 | 2 | 12161443 | ||
| Pubmed | 3.67e-05 | 6 | 55 | 2 | 22685266 | ||
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 16061479 | ||
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 25460509 | ||
| Pubmed | A Zeb2-miR-200c loop controls midbrain dopaminergic neuron neurogenesis and migration. | 6.83e-05 | 8 | 55 | 2 | 30271956 | |
| Pubmed | 6.83e-05 | 8 | 55 | 2 | 12714599 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 8.60e-05 | 908 | 55 | 8 | 19274049 | |
| Pubmed | 8.78e-05 | 9 | 55 | 2 | 9300697 | ||
| Pubmed | 8.78e-05 | 9 | 55 | 2 | 24769727 | ||
| Pubmed | Maternal diabetes induces senescence and neural tube defects sensitive to the senomorphic rapamycin. | 1.10e-04 | 10 | 55 | 2 | 34193422 | |
| Pubmed | 1.34e-04 | 11 | 55 | 2 | 16585392 | ||
| Pubmed | 1.71e-04 | 1285 | 55 | 9 | 35914814 | ||
| Pubmed | Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis. | 2.21e-04 | 14 | 55 | 2 | 26324903 | |
| Pubmed | 2.21e-04 | 14 | 55 | 2 | 35320721 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.34e-04 | 351 | 55 | 5 | 38297188 | |
| Pubmed | Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. | 2.54e-04 | 15 | 55 | 2 | 20410501 | |
| Pubmed | 2.54e-04 | 15 | 55 | 2 | 15509711 | ||
| Pubmed | 2.54e-04 | 15 | 55 | 2 | 33158935 | ||
| Pubmed | 2.90e-04 | 16 | 55 | 2 | 36418889 | ||
| Pubmed | 2.90e-04 | 16 | 55 | 2 | 25942625 | ||
| Pubmed | 3.29e-04 | 17 | 55 | 2 | 31171776 | ||
| Pubmed | 3.72e-04 | 214 | 55 | 4 | 22199357 | ||
| Pubmed | 3.78e-04 | 215 | 55 | 4 | 35973513 | ||
| Pubmed | 5.06e-04 | 21 | 55 | 2 | 19592578 | ||
| Pubmed | Loss of Sip1 leads to migration defects and retention of ectodermal markers during lens development. | 5.06e-04 | 21 | 55 | 2 | 24161570 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 5.24e-04 | 1496 | 55 | 9 | 32877691 | |
| Pubmed | 5.56e-04 | 22 | 55 | 2 | 34254395 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 5.75e-04 | 1203 | 55 | 8 | 29180619 | |
| Pubmed | 6.26e-04 | 105 | 55 | 3 | 9628581 | ||
| Pubmed | 6.63e-04 | 24 | 55 | 2 | 25348719 | ||
| Pubmed | 6.63e-04 | 24 | 55 | 2 | 29871923 | ||
| Pubmed | 6.77e-04 | 251 | 55 | 4 | 28077445 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 6.98e-04 | 109 | 55 | 3 | 33554859 | |
| Pubmed | A single-cell time-lapse of mouse prenatal development from gastrula to birth. | 7.20e-04 | 25 | 55 | 2 | 38355799 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 7.28e-04 | 256 | 55 | 4 | 35777956 | |
| Pubmed | Maternal DNA Methylation Regulates Early Trophoblast Development. | 9.04e-04 | 28 | 55 | 2 | 26812015 | |
| Pubmed | 9.04e-04 | 28 | 55 | 2 | 32005677 | ||
| Pubmed | 1.11e-03 | 31 | 55 | 2 | 23312518 | ||
| Pubmed | 1.13e-03 | 497 | 55 | 5 | 23414517 | ||
| Pubmed | 1.18e-03 | 32 | 55 | 2 | 27806288 | ||
| Pubmed | 1.49e-03 | 36 | 55 | 2 | 35379950 | ||
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.58e-06 | 718 | 38 | 10 | 28 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.44e-04 | 15 | 38 | 2 | 529 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-06 | 171 | 55 | 5 | 0eea035fde32cc2a75a0d4227911edb5d54ed47e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 195 | 55 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-06 | 196 | 55 | 5 | 83aeb96a33802949238d8a097086a1812201d1b5 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.79e-06 | 200 | 55 | 5 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-05 | 135 | 55 | 4 | b444005987093efab3265201b3541d7941816cc2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.19e-05 | 146 | 55 | 4 | c0e1836845c083bf9d88a620da27acbfdea9fb20 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.83e-05 | 153 | 55 | 4 | 764fb5e5fa028c137b8ea65dcd5e4ec9b22191e9 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 156 | 55 | 4 | d72c2f5f72d269e29033f8728d924e0d4c8772c7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.67e-05 | 161 | 55 | 4 | a480107b1c7773f2081afca2657e0b7fc88a5645 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.90e-05 | 163 | 55 | 4 | 466c8129852a5b16cd9fcc6b79e799abc21bb21a | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.02e-05 | 164 | 55 | 4 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 165 | 55 | 4 | 8c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.05e-05 | 179 | 55 | 4 | bc95c3e7edc5fc6fc913b09f087d221df64c6f48 | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 8.52e-05 | 188 | 55 | 4 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.70e-05 | 189 | 55 | 4 | 3169476f98b7385706cb618c9ad64ae83a290ef0 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.06e-05 | 191 | 55 | 4 | 6cb2c107bc674aa173b4009f320a1687a76f3979 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.06e-05 | 191 | 55 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.25e-05 | 192 | 55 | 4 | 5795ad6605565ce194341d08c65aae4b526dac84 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.43e-05 | 193 | 55 | 4 | ba484fa1f290a92ae02475a4c468b4ac840c133e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.62e-05 | 194 | 55 | 4 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.62e-05 | 194 | 55 | 4 | 54975e663ed4414b99b3c9a1aa6335613946470f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-05 | 195 | 55 | 4 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-05 | 195 | 55 | 4 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-05 | 195 | 55 | 4 | 3e24570def013d5b0b1ef1d7a5ced7dfd922590b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.82e-05 | 195 | 55 | 4 | 37aa6e4123d37de4de42ca68d3020f2a7686ce02 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-05 | 195 | 55 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-04 | 196 | 55 | 4 | a6a52cafd7c9994bc3d2f68b15a1491cd96ef908 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-04 | 196 | 55 | 4 | b1abecc0aafc09ca70a5fde624f2a998c4aa3341 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 197 | 55 | 4 | d2a4d7e92e91bcc47a7657da2e5c8a3ad7eb08ad | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-04 | 198 | 55 | 4 | 4e598aab92141e7d32ec963291ddeed14a21beba | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.08e-04 | 200 | 55 | 4 | d92d3bc63a56a604d7b1d49e62d4304e5e4017f2 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 55 | 4 | 71cbefbef4ae5bbb5f6e419914f4b3b3b5a5f9e3 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| Drug | Dydrogesterone [152-62-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 4.82e-07 | 198 | 55 | 7 | 2811_UP | |
| Disease | Vitiligo | 3.86e-05 | 101 | 55 | 4 | EFO_0004208 | |
| Disease | Malignant neoplasm of breast | 1.53e-04 | 1074 | 55 | 9 | C0006142 | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 2.22e-04 | 12 | 55 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | Mammary Neoplasms, Human | 4.27e-04 | 525 | 55 | 6 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 4.27e-04 | 525 | 55 | 6 | C4704874 | |
| Disease | Mammary Neoplasms | 4.36e-04 | 527 | 55 | 6 | C1458155 | |
| Disease | Breast Carcinoma | 4.86e-04 | 538 | 55 | 6 | C0678222 | |
| Disease | unipolar depression, age at onset | 2.54e-03 | 40 | 55 | 2 | EFO_0003761, EFO_0004847 | |
| Disease | renal cell carcinoma | 2.80e-03 | 42 | 55 | 2 | EFO_0000681 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DERAIMTYVSCFYHA | 241 | P35609 | |
| RKCESDLRHYYDSTI | 171 | P10144 | |
| RRYCTSSEVAAHYCK | 1271 | Q99758 | |
| HTREKIYAICSDYAF | 61 | Q86UB2 | |
| RFKSYEHCFTAAEAV | 36 | Q8WUY9 | |
| HTAASLFKEMCYRYR | 111 | P28072 | |
| TCRYRAFRDDDGHYS | 826 | Q6IWH7 | |
| FKCTRHRISYKTAYR | 61 | A6BM72 | |
| HCFKRYGNSTRSYAV | 676 | P56730 | |
| FRCRSHVRDYRKYSE | 76 | A1A4G5 | |
| VSTAYAYCNRKHIDE | 151 | Q8WVX9 | |
| KEAEAFAYYRRTHTA | 2416 | Q8IWI9 | |
| FYKEAIEHCRSYNSR | 16 | Q92784 | |
| VRPACTDKDYFYTHT | 326 | Q6UXG2 | |
| KRGRLYASEHYSAEC | 101 | P11487 | |
| HKTSGKRYVYRFVCD | 431 | P15036 | |
| RSIVFDSEYCRYHCR | 461 | Q86TG7 | |
| SDERAAYFRCYHKVT | 46 | Q9P104 | |
| NRLLECYFTRSFYKH | 4121 | Q7Z6Z7 | |
| YFARDAAYSSRFCKD | 236 | Q9NR21 | |
| TYCRKIALSYAHSTD | 211 | Q9Y2I7 | |
| AVFSCLYRHAYRTEE | 591 | Q92896 | |
| VSFYNMRDRSHIYTC | 461 | Q7KYR7 | |
| EYYEFRHTQVCKASA | 331 | Q5D0E6 | |
| DCSRALSYYEKSDTH | 916 | Q96RY7 | |
| YAHFAVCYRIKESSG | 201 | Q9Y597 | |
| SRAAEFYAKVALYCA | 21 | O15120 | |
| ERAQARYEKHYSVCA | 416 | Q9C093 | |
| GHCLFYYKDSREESV | 81 | Q9H4M7 | |
| CFRLHNDRVYYVSEK | 36 | Q9Y221 | |
| EKYGFITYRCSEHAA | 941 | Q86YN6 | |
| RCLHEFVKSQTTYYA | 251 | Q9NR46 | |
| DYVDTYHAAALRGKC | 231 | Q9P2R6 | |
| ARFYKHLDRGYNSCA | 1131 | Q9P2R6 | |
| SEYSCRELHFTRYVT | 76 | Q9BQB4 | |
| TAKYRAAHVFFTDSC | 96 | P61764 | |
| KDFSTSCRAHFERYL | 386 | O15204 | |
| KIADYLTRYEHFSSC | 266 | Q8TCG1 | |
| CHLRKERCQYYTASF | 441 | Q12884 | |
| CTYCSKAFRDSYHLR | 76 | Q14119 | |
| SFQARRYVAARCTHY | 541 | P41226 | |
| SYFRKECGRDLEFSH | 101 | Q8IX01 | |
| CKFVFYYHRVGTRVS | 121 | Q9GZP7 | |
| TYDGRCIFYDTEHLK | 711 | Q5JSH3 | |
| SKAFSFYSSYLRHER | 231 | Q96GE5 | |
| AGRYFCAYKTTASHE | 91 | Q6UX27 | |
| HRYSYCKREAEERDS | 981 | P37275 | |
| YLSDEHGKCRKSFYR | 381 | Q5TYW1 | |
| SKAFSFYSSYLRHER | 231 | Q9Y2A4 | |
| YCEYSTTDASGFKRH | 751 | P17010 | |
| DYICEYCARAFKSSH | 371 | Q96JP5 | |
| HYCNKVFALAEYRTR | 491 | Q8NAP3 | |
| CSYTFAYRTQLERHM | 246 | O60315 | |
| HRYSYCKREAEEREA | 1076 | O60315 | |
| CSKAFPDYSSYLRHE | 306 | P15621 | |
| RDHGYSDVFEAYFRC | 361 | Q8NBI6 | |
| DHDKRAYSFCGTIEY | 211 | Q15349 |